• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Erica L. Mayer, M.D. M.P.H.


  • Gropper AB, Calvillo KZ, Dominici L, Troyan S, Rhei E, Economy KE, Tung NM, Schapira L, Meisel JL, Partridge AH, Mayer EL.Sentinel Lymph Node Biopsy in Pregnant Women with Breast Cancer.Ann Surg Oncol. 2014 Apr 23.
  • Lin NU, Freedman RA, Ramakrishna N, Younger J, Storniolo AM, Bellon JR, Come SE, Gelman RS, Harris GJ, Henderson MA, Macdonald SM, Mahadevan A, Eisenberg E, Ligibel JA, Mayer EL, Moy B, Eichler AF, Winer EP.A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases.Breast Cancer Res Treat. 2013 Nov;142(2):405-14.
  • Vaz-Luis I, Zeghibe CA, Frank ES, Sohl J, Washington KE, Silverman SG, Fonte JM, Mayer EL, Overmoyer BA, Richardson AL, Krop IE, Winer EP, Lin NU.Prospective clinical experience with research biopsies in breast cancer patients.Breast Cancer Res Treat. 2013 Nov;142(1):203-9.
  • Ruddy KJ, Desantis SD, Gelman RS, Wu AH, Punglia RS, Mayer EL, Tolaney SM, Winer EP, Partridge AH, Burstein HJ.Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.Breast Cancer Res Treat. 2013 Oct;141(3):421-7.
  • Mayer EL, Scheulen ME, Beckman J, Richly H, Duarte A, Cotreau MM, Strahs AL, Agarwal S, Steelman L, Winer EP, Dickler MN.A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer.Breast Cancer Res Treat. 2013 Jul;140(2):331-9.
  • Meisel JL, Economy KE, Calvillo KZ, Schapira L, Tung NM, Gelber S, Kereakoglow S, Partridge AH, Mayer EL.Contemporary multidisciplinary treatment of pregnancy-associated breast cancer.Springerplus. 2013 Dec;2(1):297.
  • Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis C.Six cycles of Doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: cancer and leukemia group B 40101.J Clin Oncol. 2012 Nov 20;30(33):4071-6.
  • Mayer EL, Lin NU.Long term follow-up of national surgical adjuvant breast and bowel project trial B-31: how well can we predict cardiac toxicity with trastuzumab?.J Clin Oncol. 2012 Nov 1;30(31):3769-72.
  • Mayer EL, Isakoff SJ, Klement G, Downing SR, Chen WY, Hannagan K, Gelman R, Winer EP, Burstein HJ.Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics.Breast Cancer Res Treat. 2012 Nov;136(1):169-78.
  • Carey LA, Rugo HS, Marcom PK, Mayer EL, Esteva FJ, Ma CX, Liu MC, Storniolo AM, Rimawi MF, Forero-Torres A, Wolff AC, Hobday TJ, Ivanova A, Chiu WK, Ferraro M, Burrows E, Bernard PS, Hoadley KA, Perou CM, Winer EP.TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.J Clin Oncol. 2012 Jul 20;30(21):2615-23.
  • Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FA.Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab.J Clin Oncol. 2011 Jan 4.
  • Curigliano G, Mayer EL, Burstein HJ, Winer EP, Goldhirsch A.Cardiac toxicity from systemic cancer therapy: a comprehensive review.Prog Cardiovasc Dis.;53(2):94-104. Review.
  • Mayer EL, Krop IE.Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.Clin Cancer Res. 2010 Jul 15;16(14):3526-32.
  • Mayer EL, Burstein HJ.Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer.J Clin Oncol. 2008 Mar 10;26(8):1198-200.
  • Mayer EL, Carey LA, Burstein HJ.Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.Breast Cancer Res. 2007;9(5):110.
  • Mayer EL, Burstein HJ.Chemotherapy for metastatic breast cancer.Hematol Oncol Clin North Am. 2007 Apr;21(2):257-72. Review.
  • Mayer EL, Lin NU, Burstein HJ.Novel approaches to advanced breast cancer: bevacizumab and lapatinib.J Natl Compr Canc Netw. 2007 Mar;5(3):314-23. Review.